236 related articles for article (PubMed ID: 27658932)
21. Urinary exosomes: Potential biomarkers for diabetic nephropathy.
Sinha N; Kumar V; Puri V; Nada R; Rastogi A; Jha V; Puri S
Nephrology (Carlton); 2020 Dec; 25(12):881-887. PubMed ID: 32323449
[TBL] [Abstract][Full Text] [Related]
22. Multicentric validation of proteomic biomarkers in urine specific for diabetic nephropathy.
Alkhalaf A; Zürbig P; Bakker SJ; Bilo HJ; Cerna M; Fischer C; Fuchs S; Janssen B; Medek K; Mischak H; Roob JM; Rossing K; Rossing P; Rychlík I; Sourij H; Tiran B; Winklhofer-Roob BM; Navis GJ;
PLoS One; 2010 Oct; 5(10):e13421. PubMed ID: 20975990
[TBL] [Abstract][Full Text] [Related]
23. Adipokine zinc-alpha-2-glycoprotein as a novel urinary biomarker presents earlier than microalbuminuria in diabetic nephropathy.
Wang Y; Li YM; Zhang S; Zhao JY; Liu CY
J Int Med Res; 2016 Apr; 44(2):278-86. PubMed ID: 26857862
[TBL] [Abstract][Full Text] [Related]
24. Detection of an earlier tubulopathy in diabetic nephropathy among children with normoalbuminuria.
Hafez MH; El-Mougy FA; Makar SH; Abd El Shaheed S
Iran J Kidney Dis; 2015 Mar; 9(2):126-31. PubMed ID: 25851291
[TBL] [Abstract][Full Text] [Related]
25. Insights into Diabetic Kidney Disease Using Urinary Proteomics and Bioinformatics.
Van JA; Scholey JW; Konvalinka A
J Am Soc Nephrol; 2017 Apr; 28(4):1050-1061. PubMed ID: 28159781
[TBL] [Abstract][Full Text] [Related]
26. [Diabetes mellitus and chronic kidney disease: Possibilities of prediction, early diagnosis, and nephroprotection in the 21st century].
Shestakova MV
Ter Arkh; 2016; 88(6):84-88. PubMed ID: 27489899
[TBL] [Abstract][Full Text] [Related]
27. Proteomics and diabetic nephropathy.
Merchant ML; Klein JB
Curr Diab Rep; 2005 Dec; 5(6):464-9. PubMed ID: 16316599
[TBL] [Abstract][Full Text] [Related]
28. Diabetic nephropathy: is it always there? Assumptions, weaknesses and pitfalls in the diagnosis.
Ioannou K
Hormones (Athens); 2017 Oct; 16(4):351-361. PubMed ID: 29518755
[TBL] [Abstract][Full Text] [Related]
29. Potential urine biomarkers for the diagnosis of prediabetes and early diabetic nephropathy based on ISN CKHDP program.
Gu D; Chen Y; Masucci M; Xiong C; Zou H; Holthofer H
Clin Nephrol; 2020; 93(1):129-133. PubMed ID: 32145759
[TBL] [Abstract][Full Text] [Related]
30. Proteomic discovery of diabetic nephropathy biomarkers.
Merchant ML; Klein JB
Adv Chronic Kidney Dis; 2010 Nov; 17(6):480-6. PubMed ID: 21044770
[TBL] [Abstract][Full Text] [Related]
31. [Novel biomarkers for diabetic nephropathy].
Araki S
Rinsho Byori; 2014 Feb; 62(2):171-9. PubMed ID: 24800493
[TBL] [Abstract][Full Text] [Related]
32. Urinary podocalyxin levels were associated with urinary albumin levels among patients with diabetes.
Shoji M; Kobayashi K; Takemoto M; Sato Y; Yokote K
Biomarkers; 2016; 21(2):164-7. PubMed ID: 26635084
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic biomarkers of diabetic nephropathy.
Ito H; Fujita H; Takahashi T
Expert Opin Med Diagn; 2008 Feb; 2(2):161-9. PubMed ID: 23485136
[TBL] [Abstract][Full Text] [Related]
34. A meta-analysis of urinary transferrin for early diagnosis of diabetic nephropathy.
Li B; Wang J; Ye W
Lab Med; 2024 Jul; 55(4):413-419. PubMed ID: 38335130
[TBL] [Abstract][Full Text] [Related]
35. Searching for novel biomarkers and new therapeutic targets of diabetic nephropathy using proteomics approaches.
Thongboonkerd V
Contrib Nephrol; 2008; 160():37-52. PubMed ID: 18401160
[TBL] [Abstract][Full Text] [Related]
36. Biomarkers for early diagnosis of type 2 diabetic nephropathy: a study based on an integrated biomarker system.
Huang M; Liang Q; Li P; Xia J; Wang Y; Hu P; Jiang Z; He Y; Pang L; Han L; Wang Y; Luo G
Mol Biosyst; 2013 Aug; 9(8):2134-41. PubMed ID: 23719966
[TBL] [Abstract][Full Text] [Related]
37. Metabolomics in diabetic nephropathy: Unveiling novel biomarkers for diagnosis (Review).
Luo Y; Zhang W; Qin G
Mol Med Rep; 2024 Sep; 30(3):. PubMed ID: 38963028
[TBL] [Abstract][Full Text] [Related]
38. Prediction of cardiovascular events, diabetic nephropathy, and mortality by albumin concentration in a spot urine sample in patients with type 2 diabetes.
Viana LV; Gross JL; Camargo JL; Zelmanovitz T; da Costa Rocha EP; Azevedo MJ
J Diabetes Complications; 2012; 26(5):407-12. PubMed ID: 22677793
[TBL] [Abstract][Full Text] [Related]
39. [Diagnosis and management of diabetic nephropathy].
Kitada M; Koya D
Nihon Rinsho; 2015 Dec; 73(12):2037-43. PubMed ID: 26666150
[TBL] [Abstract][Full Text] [Related]
40. Urinary exosomes and diabetic nephropathy: a proteomic approach.
Raimondo F; Corbetta S; Morosi L; Chinello C; Gianazza E; Castoldi G; Di Gioia C; Bombardi C; Stella A; Battaglia C; Bianchi C; Magni F; Pitto M
Mol Biosyst; 2013 Jun; 9(6):1139-46. PubMed ID: 23344851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
